Advanced Magnetics sets $10 million stock sale

MRI contrast agent developer Advanced Magnetics of Cambridge, MA, has entered into definitive agreements with institutional investors to buy 1.47 million shares of its common stock. The proceeds of the sale, which will close in the next two business days, are expected to raise gross proceeds of $10 million, the company said.

By AuntMinnie.com staff writers
July 3, 2003

Related Reading

Advanced Magnetics falls into red in Q1, January 16, 2003

MRI agent detects lymph node disease in prostate and renal cancers, December 4, 2002

Advanced Magnetics revenues decline, November 25, 2002

NCI to study Advanced Magnetics agents, October 1, 2002

Contrast agents herald new progress in MR lymphography, August 9, 2002

Copyright © 2003 AuntMinnie.com

Page 1 of 611
Next Page